The Journal of Rheumatology: 34 (3)

March 01, 2007; Volume 34,Issue 3

You have access
Education in musculoskeletal health--how can it be improved to meet growing needs?
Anthony D Woolf and Kristina Akesson

The Journal of Rheumatology March 1 2007, 34 (3) 455-457;
You have access
Curriculum design: finding a balance.
Lori J Albert

The Journal of Rheumatology March 1 2007, 34 (3) 458-459;
You have access
Rheumatoid arthritis and diabetes mellitus: evidence for an association?
Michele Doran

The Journal of Rheumatology March 1 2007, 34 (3) 460-462;
You have access
Is minimal clinically important difference relevant for the interpretation of clinical trials in pediatric rheumatic diseases?
Nicolino Ruperto

The Journal of Rheumatology March 1 2007, 34 (3) 463-465;
You have access
Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis.
Michael A Mont, Slif D Ulrich and Thorsten M Seyler

The Journal of Rheumatology March 1 2007, 34 (3) 466-468;
You have access
Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older.
Julia F Simard and Murray A Mittleman

The Journal of Rheumatology March 1 2007, 34 (3) 469-473;
You have access
Infliximab does not suppress the tuberculin skin test (purified protein derivative).
Gulen Hatemi, Melike Melikoglu, Izzet Fresko, Seval Masatlioglu, Koray Tascilar and Hasan Yazici

The Journal of Rheumatology March 1 2007, 34 (3) 474-480;
You have access
Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time.
Kerstin Eberhardt, Britt-Marie Larsson, Kerstin Nived and Elisabet Lindqvist

The Journal of Rheumatology March 1 2007, 34 (3) 481-487;
You have access
Adipose tissue as a modulator of clinical inflammation: does obesity reduce the prevalence of rheumatoid arthritis?
Tamas Bartfai, Jill Waalen and Joel N Buxbaum

The Journal of Rheumatology March 1 2007, 34 (3) 488-492;
You have access
Toll-like receptor expression in lupus peripheral blood mononuclear cells.
Kiyoshi Migita, Taichiro Miyashita, Yumi Maeda, Minoru Nakamura, Hiroshi Yatsuhashi, Hironori Kimura, Hiromi Ishibashi and Katsumi Eguchi

The Journal of Rheumatology March 1 2007, 34 (3) 493-500;
You have access
Outcome measurements in scleroderma: results from a delphi exercise.
Hashim Gazi, Janet E Pope, Philip Clements, Thomas A Medsger, Richard W Martin, Peter A Merkel, Bashar Kahaleh, Frank A Wollheim, Murray Baron, Mary Ellen Csuka, Paul Emery, Jill F Belch, Samina Hayat, Edward V Lally, Joseph H Korn, Laszlo Czirjak, Ariane Herrick, Alexander E Voskuyl, Pius Bruehlmann, Murat Inanc, Daniel E Furst, Carol Black, Michael H Ellman, Larry W Moreland, Naomi F Rothfield, Vivien Hsu, Maureen Mayes, Kevin M McKown, Thomas Krieg and James R Siebold

The Journal of Rheumatology March 1 2007, 34 (3) 501-509;
You have access
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.
Xenofon Baraliakos, Joachim Listing, Martin Rudwaleit, Jan Brandt, Rieke Alten, Gerd Burmester, Erika Gromnica-Ihle, Hildrun Haibel, Stephan Schewe, Matthias Schneider, Helmut Sörensen, Henning Zeidler, Sudha Visvanathan, Joachim Sieper and Juergen Braun

The Journal of Rheumatology March 1 2007, 34 (3) 510-515;
You have access
Low molecular weight phenotype of Apo(a) is a risk factor of corticosteroid-induced osteonecrosis of the femoral head after renal transplant.
Tetsurou Hirata, Mikihiro Fujioka, Kenji A Takahashi, Takeshi Asano, Masashi Ishida, Kiyokazu Akioka, Masahiko Okamoto, Norio Yoshimura, Yoshiko Satomi, Hoyoku Nishino, Yoshio Hirota, Shigeo Nakajima, Shigeaki Kato and Toshikazu Kubo

The Journal of Rheumatology March 1 2007, 34 (3) 516-522;
You have access
Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent.
Jan Bondeson, Sarah Lauder, Shane Wainwright, Nick Amos, Amy Evans, Clare Hughes, Marc Feldmann and Bruce Caterson

The Journal of Rheumatology March 1 2007, 34 (3) 523-533;
You have access
A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee.
Paul Grootendorst, Deborah Marshall, Dan Pericak, Nicholas Bellamy, David Feeny and George W Torrance

The Journal of Rheumatology March 1 2007, 34 (3) 534-542;
You have access
Tramadol for osteoarthritis: a systematic review and metaanalysis.
M Soledad Cepeda, Francisco Camargo, Carlota Zea and Lina Valencia

The Journal of Rheumatology March 1 2007, 34 (3) 543-555;
You have access
Cyclic compression loaded on cartilage explants enhances the production of reactive oxygen species.
Takashi Tomiyama, Kanji Fukuda, Kenji Yamazaki, Kazuki Hashimoto, Hironobu Ueda, Shigeshi Mori and Chiaki Hamanishi

The Journal of Rheumatology March 1 2007, 34 (3) 556-562;
You have access
Evaluation of the activity of an academic rheumatology consult service over 10 years: using data to shape curriculum.
Kent Ta and Gregory C Gardner

The Journal of Rheumatology March 1 2007, 34 (3) 563-566;
You have access
Canadian multidisciplinary core curriculum for musculoskeletal health.
Veronica M R Wadey, En-Tzu Tang, Gregory Abelseth, Parvati Dev, Richard A Olshen and Decker Walker

The Journal of Rheumatology March 1 2007, 34 (3) 567-580;
You have access
The Quality of My Life questionnaire: the minimal clinically important difference for pediatric rheumatology patients.
Grace W K Gong, Nancy L Young, Helen Dempster, Michelle Porepa and Brian M Feldman

The Journal of Rheumatology March 1 2007, 34 (3) 581-587;
You have access
Mycophenolate mofetil and intravenous dexamethasone in the treatment of persistent lupus myelitis.
Paola Tomietto, Serena D'Agostini, Virginia Annese, Salvatore De Vita and Gianfranco Ferraccioli

The Journal of Rheumatology March 1 2007, 34 (3) 588-591;
You have access
Rapid acetabular osteolysis secondary to subchondral insufficiency fracture.
Takuaki Yamamoto, Robert Schneider, Yukihide Iwamoto and Peter G Bullough

The Journal of Rheumatology March 1 2007, 34 (3) 592-595;
You have access
Joint destruction in septic arthritis.
Imad Uthman

The Journal of Rheumatology March 1 2007, 34 (3) 596;
You have access
The World Health Organisation International Classification of Functioning, Disability and Health: a conceptual model and interface for the OMERACT process.
Gerold Stucki, Annelies Boonen, Peter Tugwell, Alarcos Cieza and Maarten Boers

The Journal of Rheumatology March 1 2007, 34 (3) 600-606;
You have access
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.
Marissa N Lassere, Kent R Johnson, Maarten Boers, Peter Tugwell, Peter Brooks, Lee Simon, Vibeke Strand, Philip G Conaghan, Mikkel Ostergaard, Walter P Maksymowych, Robert Landewe, Barry Bresnihan, Paul-Peter Tak, Richard Wakefield, Philip Mease, Clifton O Bingham 3rd, Michael Hughes, Doug Altman, Marc Buyse, Sally Galbraith and George Wells

The Journal of Rheumatology March 1 2007, 34 (3) 607-615;
You have access
Simulation studies of surrogate endpoint validation using single trial and multitrial statistical approaches.
Marissa Lassere, Kent Johnson, Michael Hughes, Doug Altman, Marc Buyse, Sally Galbraith and George Wells

The Journal of Rheumatology March 1 2007, 34 (3) 616-619;
You have access
Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers.
Barry Bresnihan, Danielle M Gerlag, Terence Rooney, Tom J M Smeets, Carla A Wijbrandts, David Boyle, Oliver Fitzgerald, Bruce W Kirkham, Iain B McInnes, Malcolm Smith, Ann-Kristin Ulfgren, Douglas J Veale and Paul P Tak

The Journal of Rheumatology March 1 2007, 34 (3) 620-622;
You have access
Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.
Stephanie O Keeling, Robert Landewe, Desiree van der Heijde, Joan Bathon, Maarten Boers, Patrick Garnero, Piet Geusens, Hani El-Gabalawy, Robert D Inman, Virginia B Kraus, Tore K Kvien, Philip J Mease, Mikkel Ostergaard, Chris Ritchlin, Silje W Syversen and Walter P Maksymowych

The Journal of Rheumatology March 1 2007, 34 (3) 623-633;
You have access
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials.
Walter P Maksymowych, Robert Landewe, Maarten Boers, Patrick Garnero, Piet Geusens, Hani El-Gabalawy, Dick Heinegard, Virginia B Kraus, Virginia Krause, Stefan Lohmander, John Matyas, Tore Saxne and Desiree van der Heijde

The Journal of Rheumatology March 1 2007, 34 (3) 634-640;
You have access
Assessing single joints in arthritis clinical trials.
Jon T Giles, Philip Mease, Maarten Boers, Barry Bresnihan, Philip G Conaghan, Alison Heald, Walter P Maksymowych, Jean-Francis Maillefert, Lee Simon, Wayne Tsuji, Richard Wakefield, Thasia Woodworth, H Ralph Schumacher and Clifton O Bingham 3rd

The Journal of Rheumatology March 1 2007, 34 (3) 641-647;
You have access
Sarcoid-like granulomatous disease following etanercept treatment for RA.
Alex Kudrin, Edwin R Chilvers, Amel Ginawi, Brian L Hazleman, Meryl H Griffiths, Sathia Thiru and Andrew J K Ostor

The Journal of Rheumatology March 1 2007, 34 (3) 648-649;
You have access
C-reactive protein in primary antiphospholipid syndrome.
Paul R J Ames, Catello Tommasino, Vincenzo Brancaccio and Antonio Ciampa

The Journal of Rheumatology March 1 2007, 34 (3) 650;

Main menu

User menu

Search

Table of Contents

In this issue

Content

Resources

Subscribers

More